KannaLife Sciences, Inc. — Form D
KannaLife Sciences, Inc. of West Hills, NY, a company, filed a Form D exempt-offering notice with the SEC on 2013-04-30. The offering totals $1.5M, of which $1.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-04-30
- Form: D
- Accession: 0001538856-13-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $1.5M
- Amount sold: $1.5M
- Investors: 2
- Date of first sale: 2013-03-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-195740
Issuer
- Name: KannaLife Sciences, Inc.
- CIK: 0001538856
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 363 West Hills Road, West Hills, NY, 11743
- Phone: 516.669.3219
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Thoma Kikis | Director | West Hills, NY |
| Michael Mona, Jr. | Director | LAS VEGAS, NV |
| Dean Petkanas | Director | Lloyd Harbor, NY |
| Stuart Titus | Director | Poway, CA |
| Mark Corrao | Executive Officer | Miramar, FL |
| Thoma Kikis | Executive Officer | West Hills, NY |
| Dean Petkanas | Executive Officer | Lloyd Harbor, NY |
| W. Dennis Drehkoff | Director | Oak Brook, IL |
| W. Dennis Drehkoff | Executive Officer | Oak Brook, IL |
| Thomas Dennis Kikis | Director | Flushing, NY |
| Thomas Dennis Kikis | Executive Officer | Flushing, NY |
| Ramesh Dennis Pandey | Director | Highland Park, NJ |
| Ramesh Dennis Pandey | Executive Officer | Highland Park, NJ |
Other filings by this issuer (1)
More